Literature DB >> 16510566

Chromosomal instability in MYH- and APC-mutant adenomatous polyps.

Joana Cardoso1, Lia Molenaar, Renee X de Menezes, Monique van Leerdam, Carla Rosenberg, Gabriela Möslein, Julian Sampson, Hans Morreau, Judith M Boer, Riccardo Fodde.   

Abstract

The vast majority of colorectal cancers display genetic instability, either in the chromosomal instability (CIN) or microsatellite instability (MIN) forms. Although CIN tumors are per definition aneuploid, MIN colorectal cancers, caused by loss of mismatch repair function, are usually near diploid. Recently, biallelic germ line mutations in the MYH gene were found to be responsible for MYH-associated polyposis (MAP), an autosomal recessive predisposition to multiple colorectal polyps, often indistinguishable from the dominant familial adenomatous polyposis (FAP) syndrome caused by inherited APC mutations. Here, we analyzed MYH- and APC-mutant polyps by combining laser capture microdissection, isothermal genomic DNA amplification, and array comparative genomic hybridization. Smoothed quantile regression methods were applied to the MAP and FAP genomic profiles to discriminate chromosomes predominantly affected by gains and losses. Up to 80% and 60% of the MAP and FAP polyps showed aneuploid changes, respectively. Both MAP and FAP adenomas were characterized by frequent losses at chromosome 1p, 17, 19, and 22 and gains affecting chromosomes 7 and 13. The aneuploid changes detected at early stages of MYH-driven tumorigenesis may underlie accelerated tumor progression, increased cancer risk, and poor prognosis in MAP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510566     DOI: 10.1158/0008-5472.CAN-05-2407

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Aneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and human.

Authors:  Paola Alberici; Emma de Pater; Joana Cardoso; Mieke Bevelander; Lia Molenaar; Jos Jonkers; Riccardo Fodde
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  APC2 and Axin promote mitotic fidelity by facilitating centrosome separation and cytoskeletal regulation.

Authors:  John S Poulton; Frank W Mu; David M Roberts; Mark Peifer
Journal:  Development       Date:  2013-09-11       Impact factor: 6.868

Review 3.  DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.

Authors:  S Solier; Y-W Zhang; A Ballestrero; Y Pommier; G Zoppoli
Journal:  Curr Cancer Drug Targets       Date:  2012-05       Impact factor: 3.428

Review 4.  Application of quantile regression to recent genetic and -omic studies.

Authors:  Laurent Briollais; Gilles Durrieu
Journal:  Hum Genet       Date:  2014-04-26       Impact factor: 4.132

Review 5.  When you're strange: Unusual features of the MUTYH glycosylase and implications in cancer.

Authors:  Alan G Raetz; Sheila S David
Journal:  DNA Repair (Amst)       Date:  2019-06-08

Review 6.  The chromosomal instability pathway in colon cancer.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

7.  Pathological features of colorectal carcinomas in MYH-associated polyposis.

Authors:  A M O'Shea; S P Cleary; M A Croitoru; H Kim; T Berk; N Monga; R H Riddell; A Pollett; S Gallinger
Journal:  Histopathology       Date:  2008-06-28       Impact factor: 5.087

8.  Micronucleus analysis in patients with colorectal adenocarcinoma and colorectal polyps.

Authors:  Ali Karaman; Doğan Nasir Binici; Mehmet Eşref Kabalar; Züleyha Calikuşu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

9.  Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.

Authors:  Yang Wang; Robert J Coffey; Neil Osheroff; Kristi L Neufeld
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

Review 10.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.